100 related articles for article (PubMed ID: 33517285)
1. Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
Lee HP; Tsai KW; Lee CC
Anticancer Res; 2021 Feb; 41(2):803-810. PubMed ID: 33517285
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
3. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
4. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
6. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour.
Yang Y; Zhen T; Zhang F; Dai S; Kang L; Liang Y; Xue L; Han A
J Clin Pathol; 2014 Mar; 67(3):235-42. PubMed ID: 24072730
[TBL] [Abstract][Full Text] [Related]
7. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
8. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors.
Chang KC; Tai MH; Lin JW; Wang CC; Huang CC; Hung CH; Chen CH; Lu SN; Lee CM; Changchien CS; Hu TH
Int J Cancer; 2007 Sep; 121(5):1059-65. PubMed ID: 17487837
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
10. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Uyama H; Tomita Y; Nakamura H; Nakamori S; Zhang B; Hoshida Y; Enomoto H; Okuda Y; Sakon M; Aozasa K; Kawase I; Hayashi N; Monden M
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6043-8. PubMed ID: 17062679
[TBL] [Abstract][Full Text] [Related]
11. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
13. [Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].
Zhang J; Qi J; Guo Y; Guo Y; Fu W; Zhou B; Wu G; Han L; He A
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):211-8. PubMed ID: 21426662
[TBL] [Abstract][Full Text] [Related]
14. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
[TBL] [Abstract][Full Text] [Related]
15. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Wang S; Fang W
Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
[TBL] [Abstract][Full Text] [Related]
17. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
18. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.
Tsai CC; Huang SC; Tai MH; Chien CC; Huang CC; Hsu YC
Int J Mol Sci; 2014 Nov; 15(11):21492-504. PubMed ID: 25421244
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
